Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 6;86(5):468-473.
doi: 10.1292/jvms.23-0526. Epub 2024 Apr 2.

Antimicrobial resistance patterns of Streptococcus uberis isolates from bovine milk in Chiba prefecture, Japan: association between multidrug resistance and clonal complex 996

Affiliations

Antimicrobial resistance patterns of Streptococcus uberis isolates from bovine milk in Chiba prefecture, Japan: association between multidrug resistance and clonal complex 996

Yuzo Tsuyuki et al. J Vet Med Sci. .

Abstract

Streptococcus uberis is one of major pathogens causing bovine mastitis. However, there is poor information on antimicrobial resistance (AMR) among the Japanese isolates. To provide treatment information for the mastitis caused by S. uberis in Japan, we aimed to clarify AMR patterns of the isolates from bovine milk mainly in Chiba. AMR phenotyping/genotyping [blaZ-erm(A)-erm(B)-mef(A)-linB-lnuD-tet(M)-tet(O)-tet(K)-tet(L)-tet(S)] and multilocus sequence typing were performed to analyze relationships between AMR patterns and clonal complexes (CCs). Resistance to tetracycline-, macrolide-, and lincosamide-classes was mainly associated with possession of tet(O), tet(S), erm(B), linB, and lnuD genes. CC996 was significantly associated with multidrug resistance (P<0.0001). These findings will aid Chiba farm animal clinics in treating bovine mastitis.

Keywords: Chiba; Streptococcus uberis; antimicrobial resistance; bovine milk; clonal complex.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Similar articles

Cited by

References

    1. Clinical and Laboratory Standards Institute (CLSI).2016. Performance standards for antimicrobial susceptibility testing; 26th informational supplement. M100-S26. CLSI, Wayne.
    1. Coffey TJ, Pullinger GD, Urwin R, Jolley KA, Wilson SM, Maiden MC, Leigh JA. 2006. First insights into the evolution of Streptococcus uberis: a multilocus sequence typing scheme that enables investigation of its population biology. Appl Environ Microbiol 72: 1420–1428. doi: 10.1128/AEM.72.2.1420-1428.2006 - DOI - PMC - PubMed
    1. Davies PL, Leigh JA, Bradley AJ, Archer SC, Emes RD, Green MJ. 2016. Molecular epidemiology of Streptococcus uberis clinical mastitis in dairy herds: strain heterogeneity and transmission. J Clin Microbiol 54: 68–74. doi: 10.1128/JCM.01583-15 - DOI - PMC - PubMed
    1. Fukushima Y, Tsuyuki Y, Goto M, Yoshida H, Takahashi T. 2019. Species identification of β-hemolytic streptococci from diseased companion animals and their antimicrobial resistance data in Japan (2017). Jpn J Infect Dis 72: 94–98. doi: 10.7883/yoken.JJID.2018.231 - DOI - PubMed
    1. Haenni M, Saras E, Bertin S, Leblond P, Madec JY, Payot S. 2010. Diversity and mobility of integrative and conjugative elements in bovine isolates of Streptococcus agalactiae, S. dysgalactiae subsp. dysgalactiae, and S. uberis. Appl Environ Microbiol 76: 7957–7965. doi: 10.1128/AEM.00805-10 - DOI - PMC - PubMed

Substances

Supplementary concepts